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Context: Although the consequences of severe iodine deficiency are beyond doubt, the effects of
mild to moderate iodine deficiency in pregnancy on child neurodevelopment are less well
established.
Objective: To study the association between maternal iodine status during pregnancy and child IQ
and identify vulnerable time windows of exposure to suboptimal iodine availability.
Design:Meta-analysis of individual participant data from three prospective population-based birth
cohorts: Generation R (Netherlands), INMA (Spain), and ALSPAC (United Kingdom); pregnant
women were enrolled between 2002 and 2006, 2003 and 2008, and 1990 and 1992, respectively.
Setting: General community.
Participants: 6180mother-child pairs withmeasures of urinary iodine and creatinine concentrations
in pregnancy and child IQ. Exclusion criteria were multiple pregnancies, fertility treatment,
medication affecting the thyroid, and preexisting thyroid disease.
Main Outcome Measure: Child nonverbal and verbal IQ assessed at 1.5 to 8 years of age.
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Results: Therewas a positive curvilinear association of urinary iodine/creatinine ratio (UI/Creat) with
mean verbal IQ only. UI/Creat ,150 mg/g was not associated with lower nonverbal IQ (20.6 point;
95% CI:21.7 to 0.4 points; P5 0.246) or lower verbal IQ (20.6 point; 95% CI:21.3 to 0.1 points; P5
0.082). Stratified analyses showed that the association of UI/Creat with verbal IQ was only present
up to 14 weeks of gestation.
Conclusions: Fetal brain development is vulnerable to mild to moderate iodine deficiency, par-
ticularly in the first trimester. Our results show that potential randomized controlled trials in-
vestigating the effect of iodine supplementation inwomenwithmild tomoderate iodine deficiency
on child neurodevelopment should begin supplementation not later than the first trimester. (J Clin
Endocrinol Metab 104: 5957–5967, 2019)
Iodine is an essential trace element required for theproduction of thyroid hormones; optimal thyroid
hormone availability is important for normal fetal brain
development (1, 2). During pregnancy, there is a higher
demand for maternal iodine intake (3, 4). This is due to
(i) the increased maternal thyroid hormone synthesis
required to ensure adequate thyroid hormone availability
to the fetus, (ii) greater urinary iodine loss due to an
increased glomerular filtration rate, and (iii) placental
transfer of iodine to the fetus to facilitate fetal thyroid
hormone production. Although severe iodine deficiency
is no longer common in Europe, mild to moderate iodine
deficiency is still common, especially in pregnant women
(5). Severe iodine deficiency in pregnancy results in a
higher risk of goiter, hypothyroidism, and mental re-
tardation in the offspring (6). However, the consequences
of mild to moderate iodine deficiency in pregnancy on
child neurodevelopment are less well established (4).
Mild to moderate iodine deficiency or low iodine
intake during pregnancy has been associated with ad-
verse child neurodevelopmental outcomes in some (7–13)
but not all studies (14–16). Differences in results between
studies may be related to methodological differences
(e.g., measurement of iodine status, selected reference
group, and available data on confounders), the age
at assessment of the neurodevelopmental outcome of
interest, the timing of the iodine measurements, and the
relative severity of iodine deficiency in the population.
Although the main focus in the literature has been on
the effects of iodine deficiency, some studies have sug-
gested adverse effects of supplemental intake or excess
iodine on either maternal thyroid function (17, 18), fetal
thyroid function (19, 20), or child neurodevelopment
(10, 15, 16).
International health authorities have similar recom-
mendations to ensure optimal iodine status in pregnancy
(21–23). It is universally recognized that any necessary
iodine supplementation should be commenced before or
as early as possible in pregnancy to achieve adequate
iodine intake, owing to the susceptibility of the fetal brain
to iodine deficiency (23). However, whether the effect of
iodine on child cognition varies during different stages of
pregnancy is unknown. We therefore assessed the asso-
ciation between maternal iodine status in pregnancy and
child IQ across three cohorts of differing iodine status
and investigated potential effect modification by gesta-
tional age.
Material and Methods
Study design and populations
This study was embedded in three cohort studies: Genera-
tion R (Netherlands), the INfancia y Medio Ambiente Project
(INMA; Spain, three regions), and the Avon Longitudinal Study
of Parents and Children (ALSPAC; United Kingdom). The study
designs have been described elsewhere (24–27); the ALSPAC
study website contains details of all the data that are available
through a fully searchable data dictionary and variable search
tool (28). For the current study, mother-child pairs were in-
cluded if a measure of urinary iodine and creatinine concen-
tration during pregnancy and child IQ scores were available.
Exclusion criteria were multiple pregnancies, fertility treatment,
medication affecting the thyroid, and preexisting thyroid
disease. Ethical approval was obtained from the Medical
Ethical Committee of the Erasmus Medical Center (Generation
R); the Ethical Committee of the Municipal Institute of Medical
Investigation and the ethical committees of the hospitals in-
volved in the study (INMA); and the ALSPAC Ethics and Law
Committee and local research ethics committees; approval
was given by participants and/or parents or guardians of the
children by a signed informed consent form.
Maternal iodine status
Urinary iodine concentration (UIC) and creatinine concen-
tration were measured in spot urine samples stored at 220°C
after collection. As part of this study, additional urine samples
were analyzed for iodine and creatinine concentrations, and
existing measurements from each cohort (7, 19, 29) were also
included. The additional measurements were performed in the
same laboratories where the existing measurements were per-
formed. The laboratories were registered with EQUIP and used
certified reference materials (Seronorm Urine levels one and
two; Nycomed, Norway) for the verification of results. In
Generation R, UIC was measured by the Sandell-Kolthoff
method. In the INMA, UIC was measured using paired-ion
reversed-phase, high-performance liquid chromatography
with electrochemical detection at a silver working electrode
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(Waters Chromatography, Milford, MA). In the ALSPAC,
UIC was measured on a dynamic reaction cell inductively
coupled plasma mass spectrometer. Urinary creatinine con-
centration was determined by the Jaffe rate method in all
cohorts. More information on the measurement methods
and the variability between assays can be found in an online
repository (30).
In a subset of women, repeated measures of urinary iodine
and creatinine were available; we used the earliest available
sample as an indicator of iodine status. The urinary iodine/
creatinine ratio (UI/Creat) was used as a measure of iodine
status. Because of possible contamination of UIC by the use
of iodine-containing test strips in ALSPAC (31), UIC.500 mg/L
and/or UI/Creat .700 mg/g was excluded from the analyses in
this cohort (N 5 363). These cutoffs were based on previous
work in ALSPAC and from other studies of pregnant women in
the United Kingdom (7, 32, 33). We grouped women’s results
by UI/Creat as follows: (i) ,150 mg/g, (ii) 150 to ,500 mg/g,
and (iii) $500 mg/g; according to World Health Organization
classification, these groups broadly relate to iodine deficiency,
sufficiency, and excess, respectively.
Maternal thyroid function
TSH and free thyroxine (FT4) were measured according to
different methodologies between cohorts, which are described
in detail elsewhere (34–36). For the analysis, FT4 and TSH
concentrations were logarithmically transformed, and cohort-
specific SD scores were calculated with a mean of 0 and an SD
of 1 based on the data of thyroid peroxidase antibody
(TPOAb)-negative women (TPOAb measurements were
available in Generation R and ALSPAC). TPOAb titers $60
IU/mL and$6 IU/mL were considered positive in Generation
R and ALSPAC, respectively. These cutoffs were determined
by the assay manufacturers.
Nonverbal and verbal IQ scores
In Generation R, nonverbal IQ was assessed at a median age
of 5.9 years using a subset of the Snijders Oomen Nonverbal
Intelligence Test (2.5-7-Revised) (37), and verbal IQ was
estimated by the short form of the McArthur Communicative
Development Inventory (38) at a median age of 1.5 years. In
the INMA, nonverbal and verbal IQ scores were assessed at a
median age of 4.6 years using theMcCarthy Scales of Children’s
Abilities (39). In the ALSPAC, nonverbal and verbal IQ scores
were assessed at a median age of 8.6 years using the Wechsler
Intelligence Scale for Children, third UK edition (40). Except
for verbal IQ ascertainment in Generation R, which involved a
parental questionnaire, all other measurements were performed
by psychologists or trained staff. To homogenize the different
scores, raw cohort-specific scores were standardized to a mean
of 100 and an SD of 15. Children with IQ scores,50 or.150
(n 5 3) were considered outliers and were excluded from the
analyses. Suboptimal IQ was defined as an IQ score ,85.
Potential confounding variables
Information onmaternal age, educational level (low, middle,
high), ethnicity/country of birth (cohort-specific categories),
parity (zero, one, two or more), prepregnancy body mass index,
and smoking during pregnancy (never smoked, smoked in
the beginning or until pregnancy confirmed, continued
smoking) was collected by questionnaires administered during
pregnancy. Gestational age at urine sampling was defined using
ultrasonography or last menstrual period. Child sex and age at
time of the IQ assessment was obtained during the study visits.
Statistical analyses
UI/Creat was not normally distributed and was therefore
transformed using the natural logarithm; back-transformed
values are shown in plots for better interpretation. We studied
the associations of UI/Creat with child nonverbal and verbal IQ
scores by using one-step and two-step approaches. In the one-
step approach, data from the cohorts were pooled, and we
performed standardmultivariable linear regressionmodels with
and without a quadratic term to investigate the possible non-
linear nature of the associations. Nonlinearity was also inves-
tigated by using ordinary least squares linear regression models
with restricted cubic splines with three knots. With ANOVA, we
tested the null hypothesis that child mean IQ was similar across
the full range of the natural logarithm of UI/Creat. The decision
to use linear regression models instead of multilevel models for
the one-step analyses was made because we found no difference
between multilevel models with random intercepts and/or slope
per cohort vs standard linear regression correcting for cohort
(e.g., cohort-specific variable ethnicity/country of birth) when
assessed using the Akaike information criterion and log-likelihood
tests. In the two-step approach we first studied the associations
of UI/Creat ,150 mg/g and UI/Creat $500 mg/g with child IQ
by using linear regression models in each cohort separately. In
these analyses, the reference group consisted of women with
UI/Creat of 150 to 500 mg/g. We then combined the cohort-
specific effect estimates using random-effects meta-analyses.
Potential effect modification according to gestational age
was analyzed by adding a product interaction term between
UI/Creat and gestational age to the one-step approach models.
Because of the known constraints of statistical power for in-
teraction analyses, a P value ,0.15 for interaction terms was
used to screen for potential relevant modification (41). We
further quantified potential relevant differences by performing
stratified analyses by tertiles of gestational age (#12 weeks,.12
to #14 weeks, and .14 weeks). We also studied associations
with suboptimal IQ (score ,85) by combining cohort-specific
estimates from logistic regression models into random-effects
meta-analyses.
Sensitivity analyses were designed to study (i) the associa-
tions of UI/Creat with verbal IQ score in mother-child pairs
from the INMA and ALSPAC only, as verbal IQ was assessed
at a preschool age in Generation R; (ii) the association between
UI/Creat and maternal TSH and FT4 SD scores within the
64 SD range around the mean, as TSH and FT4 values outside
this range were considered outliers (n 5 19 for TSH; n 5 5 for
FT4); and (iii) whether the association between UI/Creat and
IQ score could potentially be explained by maternal thyroid
function by adjusting for FT4 and TSH in the models.
Heterogeneity between cohorts was assessed using the
Cochran Q test and the I2 statistic (42). All models were
adjusted for potential confounding variables. However, because of
collinearity between maternal ethnicity/country of birth, child
age at IQ ascertainment, and cohort, we adjusted for maternal
ethnicity/country of birth only in the one-step approachmodels.
We applied inverse probability weighting to take into ac-
count the potential differential loss to follow-up (30) [i.e., to
account for selection bias that potentially arises when only the
population with available data on iodine status and child IQ is
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included compared with a full initial cohort recruited at
pregnancy (43)]. Briefly, we used information available for all
participants at recruitment to predict the probability of par-
ticipation in the study and used the inverse of these probabilities
as weights in the analyses so that results would be representative
of the initial populations of the cohorts. In addition, missing
values in potential confounding variables were imputed using
chained equations (44). A total of 25 data sets were generated.
A P value ,0.05 was defined as statistically significant. Sta-
tistical analyses were performed with STATA (version 14.0;
StataCorp, College Station, TX) and R statistical software
(version 3.3.2, package rms).
Results
The final study population consisted of 6180 mother-
child pairs (Fig. 1). The median UIC (UI/Creat) was
159 mg/L (214 mg/g) in Generation R (adequate intake),
128 mg/L (152 mg/g) in the INMA (mild deficiency), and
96 mg/L (124 mg/g) in the ALSPAC (moderate deficiency)
(Table 1). Iodine status was determined at a median
[interquartile range (IQR)] gestational age of 13.1 (12.1,
14.8) weeks, 13.0 (12.4, 14.1) weeks, and 12.0 (8.0, 16.0)
weeks in Generation R, the INMA, and the ALSPAC,
respectively.
Nonverbal IQ
Using pooled data in the one-step approach, we
observed a positive linear association between the UI/Creat
and mean nonverbal IQ score [Fig. 2(a) and (30)], al-
though this association was not statistically significant.
Using the two-step approach inwhichwe combined cohort-
specific effect estimates using random-effects meta-analysis,
neither UI/Creat ,150 mg/g nor UI/Creat $500 mg/g was
associated with nonverbal IQ score (20.6 point; 95%CI:
21.7 to 0.4 points; P 5 0.246 and 21.1 points, 95%CI:
24.2 to 2.0 points;P5 0.478) [Fig. 2(b) and 2(c)]. UI/Creat
was not associated with suboptimal nonverbal IQ (30).
Verbal IQ
Using the one-step approach, we observed a positive
curvilinear association between UI/Creat and verbal IQ
score [Fig. 3(a) and (30)]. There was a positive linear
association when measures in preschool children from
GenerationRwere excluded. Using the two-step approach,
neither UI/Creat ,150 mg/g nor UI/Creat $500 mg/g was
associatedwith verbal IQ score (20.6 point, 95%CI:21.3
to 0.1 points; P5 0.082 and20.6 point, 95%CI:22.6 to
1.4 points; P 5 0.552, respectively) [Fig 3(b) and 3(c) or
suboptimal verbal IQ score (30)].
Figure 1. Flowchart of selection of the study population.
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Effect modification according to gestational age
The continuous association of UI/Creat with non-
verbal IQ score did not differ according to gestational
age at measurement (P for interaction term 5 0.306).
By contrast, we identified possible effect modification by
gestational age in the association with verbal IQ (P for
interaction term 5 0.078). Stratification by tertile of
gestational age showed a positive curvilinear association
of UI/Creat with mean child verbal IQ score, with an
overall effect of;5 IQ points during the first 12 weeks of
pregnancy [Fig. 4(a) and (30)]. Furthermore, there was a
positive linear association between UI/Creat and mean
child verbal IQ score during the 12th to 14th weeks
of pregnancy, with an overall effect of ;3 IQ points
[Fig. 4(b)]. This association was no longer present after
the 14th week of pregnancy [Fig. 4(c)].
Table 1. Population Characteristics
Generation R (n5 1931) INMA (n 5 1269) ALSPAC (n 5 2980)
n Values n Values n Values
Offspring neurodevelopment, no. (%)
Suboptimal nonverbal IQa 1540 175 (11.4) 1269 216 (17.0) 2979 479 (16.1)
Suboptimal verbal IQa 1618 279 (17.2) 1269 211 (16.6) 2977 480 (16.1)
Female sex, no. (%) 1931 963 (49.9) 1268 632 (49.8) 2980 1514 (50.8)
Iodine status 1931 1269 2980
UI/Creat, mg/g, median (IQR) 214 (143–308) 152 (96–258) 124 (82–199)
UI/Creat ,150 mg/g, no. (%) 531 (27.5) 623 (49.1) 1831 (61.4)
UI/Creat .500 mg/g, no. (%) 97 (5.0) 52 (4.1) 81 (2.7)
UIC, mg/L, median (IQR) 159 (90–275) 128 (75–213) 96 (57–153)
Gestational age at urine sampling, wk 1931 1267 2980
Median (IQR) 13.1 (12.1–14.8) 13.0 (12.4–14.1) 12.0 (8.0–16.0)
Range (min–max) 6.1–30.5 8.6–39.4 1.0–42.0
.20th week of gestation, no. (%) 66 (3.4) 130 (10.2) 211 (7.1)
Maternal thyroid function
TSH, mIU/L, median (IQR) 1719 1.29 (0.79–1.95) 1227 1.25 (0.85–1.80) 1102 0.97 (0.64–1.38)
FT4, pmol/L, median (IQR) 1728 14.6 (12.9–16.5) 1229 10.6 (9.7–11.6) 1108 16.2 (14.9–17.7)
TPOAb positivity, no. (%) 1737 98 (5.6) NA NA 1111 146 (13.1)
Gestational age, wk, mean (SD) 1733 13.3 (1.9) 1228 13.2 (1.4) 1118 10.3 (2.7)
Educational level, no. (%) 1835 1265 2888
Low 154 (8.4) 270 (21.3) 573 (19.8)
Middle 760 (41.4) 525 (41.5) 1810 (62.7)
High 921 (50.2) 470 (37.2) 505 (17.5)
Maternal ethnicity/country of birth, no. (%) 1803 1266 2877
Spanish NA 1184 (93.5) NA
Latin-American NA 56 (4.4) NA
European/other NA 26 (2.1) NA
Dutch 1012 (53.2) NA NA
Indonesian 69 (3.6) NA NA
Cape Verdean 58 (3.1) NA NA
Moroccan 115 (6.0) NA NA
Surinamese 154 (8.1) NA NA
Turkish 170 (9.0) NA NA
Other, non-Western 150 (7.9) NA NA
Other, Western 174 (9.1) NA NA
White NA NA 2841 (98.7)
Nonwhite NA NA 36 (1.3)
Maternal age, y, mean (SD) 1931 30.5 (4.8) 1257 31.6 (3.9) 2980 28.6 (4.5)
Parity, no. (%) 1931 1267 2877
0 1121 (58.1) 727 (57.4) 1346 (46.8)
1 564 (29.2) 458 (36.1) 992 (34.5)
$2 246 (12.7) 82 (6.5) 539 (18.7)
Smoking during pregnancy, no. (%) 1744 1254 2926
Never 1319 (75.6) 870 (69.4) 2434 (83.2)
In the beginning of pregnancy 168 (9.6) 168 (13.4) 125 (4.3)
Continued 257 (14.7) 216 (17.2) 367 (12.5)
Prepregnancy BMI, kg/m2, median (IQR) 1694 22.6 (20.8–25.2) 1269 22.5 (20.8–25.0) 2713 22.2 (20.5–24.4)
Values are based on unimputed data.
Abbreviations: BMI, body mass index; IQR, interquartile range; NA, not applicable.
aSuboptimal is defined as an IQ score ,85.
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Iodine status and thyroid function
UI/Creat was not associated with TSH (0.007, 95 CI%:
20.044 to 0.058; P5 0.789) or with FT4 (20.044, 95 CI%:
20.092 to 0.005; P 5 0.079). The association did not
change between UI/Creat and child nonverbal or verbal
IQ score after adjustment for TSH and/or FT4; there was
also no sign of effect modification by TSH or FT4 (data
not shown). There was no association of UI/Creat with
TSH and FT4 in TPOAb-negative women only.
Discussion
This meta-analysis of individual participant data showed
that a lower UI/Creat during pregnancy was associated
with lower verbal IQ score. The association of UI/
Creat with verbal IQ score was only seen up to the
start of the second trimester (up to the 14th week
of gestation). In contrast, we observed no associa-
tions between IQ score and UI/Creat ,150 mg/g or
.500 mg/g.
Only a few of the previous single-center studies (i.e.,
the Generation R and ALSPAC cohort studies) focused
on child nonverbal IQ score (7, 14). They found no
association between UI/Creat ,150 mg/g and nonverbal
IQ score. It was suggested that iodine deficiency in the
Generation R cohort may not have been severe enough
for an association to be identified (14). After combining
these two cohorts of contrasting iodine status with a third
Figure 2. Association of maternal iodine status in pregnancy with child nonverbal IQ score. (a) Continuous association, depicted as the mean
child nonverbal IQ score (black line) with 95% CI (gray area) using pooled data. Models were adjusted for gestational age, child sex, maternal
ethnicity/country of birth, maternal education, parity, maternal age, prepregnancy body mass index, and smoking during pregnancy. The P value
was provided by an ANOVA test of the null hypothesis that mean child nonverbal IQ score was similar across the whole range of the natural
logarithm of UI/Creat. (b and c) Forest plots of (b) UI/Creat ,150 mg/g (“deficiency”) and (c) UI/Creat $500 mg/g (“excess”) compared with
the reference group of UI/Creat $150 to ,500 mg/g (“sufficient”), depicted as effect estimate (dot) with 95% CI per cohort and overall as
estimated by random-effects meta-analysis (diamond). Coef, coefficient.
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mildly deficient population (INMA), there was still no
effect of iodine deficiency on nonverbal IQ score.
Our meta-analysis using predefined cutoffs showed
that UI/Creat ,150 mg/g was not associated with
lower verbal IQ score. The estimates we found for the
ALSPAC contrasted with the strong negative associ-
ation of maternal UI/Creat ,150 mg/g in the first
trimester (defined as #13 weeks’ gestation) with child
verbal IQ score found in a previously published study
from that cohort (fully adjusted: 22.9, 95CI%: 25.0
to 20.8; P 5 0.006) (7). However, there are a few
important differences between the studies. Compared
with the previous publication, the ALSPAC data in
our study included a larger number of mother-child
pairs (2980 vs 958), fewer iodine-deficient women
[1831 (61.4%) vs 646 (67.4%)], a study population
with a higher UI/Creat [median UI/Creat (IQR): 124
(82 to 199) vs 110 (74 to 170)], and most notably, a
higher number of mothers with iodine status measured
after the first trimester [1135 (38%) vs 0 (0%); median
gestational age (IQR): 12 (8 to 16) weeks vs 10.0 (9 to 12)
weeks]. In addition, we adjusted our analysis for a more
stringent selection of variables. Comparison between
study populations and additional analysis of the as-
sociation between UI/Creat,150 mg/g and a verbal IQ
score in the bottom quartile in the whole cohort and in
Figure 3. Association of maternal iodine status during pregnancy with child verbal IQ score. (a) Continuous association, depicted as the mean
child verbal IQ (black line) with 95% CI (gray area) using pooled data. Models were adjusted for gestational age, child sex, maternal ethnicity/
country of birth, maternal education, parity, maternal age, prepregnancy body mass index, and smoking during pregnancy. The P value was
provided by an ANOVA test of the null hypothesis that mean child verbal IQ score was similar across the whole range of the natural logarithm of
UI/Creat. (b and c) Forest plots of (b) UI/Creat ,150 mg/g (“deficiency”) and (c) UI/Creat $500 mg/g (“excess”) compared with the reference
group of UI/Creat $150 to ,500 mg/g (“sufficient”), depicted as effect estimate (dot) with 95% CI per cohort and overall as estimated by
random-effects meta-analysis (diamond). Coef, coefficient.
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samples from#13 weeks’ gestation are described in an
online repository (30).
The importance of iodine status in the preconceptional
stage for child IQ has recently been shown (45). In early
pregnancy, the fetus is fully dependent on the placental
transfer of thyroid hormone to support the crucial
processes of brain development (2). There is a need for
optimal iodine supply from the initiation of concep-
tion, implying that sufficient intrathyroidal iodine stores
at the preconception stage may well be critical. Indeed,
our results suggest that the fetus is particularly sensitive
to suboptimal iodine status in the early stages of preg-
nancy (e.g., #14 weeks of gestation) for optimal devel-
opment of verbal IQ. Effects on verbal IQ could possibly
be explained by the impact of mild iodine deficiency, via
thyroid hormone, on the auditory system (13, 46). In our
study, we did not find evidence that the association
between UI/Creat and verbal IQ was mediated via ma-
ternal thyroid function. Possible explanations could be
that urinary iodine excretion is a highly volatile and
crude measurement of individual iodine status and/or a
crude marker of thyroidal iodine availability. Alterna-
tively, it is also possible that the effects are (in part)
mediated via fetal thyroid function.
This study confirms that low iodine status is associ-
ated with a reduction in verbal IQ scores, putting these
children at potential risk for poorer academic achieve-
ment (47). Furthermore, our findings may have impli-
cations on a national level (e.g., by negatively affecting
economic growth) (48). However, there is still in-
conclusive evidence that supplementation in pregnant
women with mild to moderate iodine deficiency is ben-
eficial for child neurodevelopment (11, 15, 16, 49–53). A
recent randomized placebo-controlled trial showed no
benefit on children’s nonverbal or verbal IQ score with
daily supplementation with 200 mg of iodine (as po-
tassium iodide) in women with mild iodine deficiency
(52). In addition to the already mentioned limitations of
that trial (54), our results provide an explanation for the
null finding; the trial randomly assigned women at up to
14 weeks of gestation, whereas we showed that maternal
iodine status is particularly important in the first tri-
mester. Although our study needs replication, it suggests
that the trial might have missed a critical period of
vulnerability in women with iodine deficiency. Our re-
sults clearly suggest that additional randomized con-
trolled trials should start with iodine supplementation
early in the first trimester or preferably even before
pregnancy.
The strengths of our study are as follows: A consistent
approach to the analysis and harmonization of potential
confounding variables across cohorts optimized compari-
sons; advanced statistical methods were used to overcome
selection bias due to loss to follow-up and missing data;
and UI/Creat was used as a marker of iodine status. The
latter has been shown to be a more valid measure of
iodine excretion when used in groups of the same age and
sex (55), though we recognize that a single measure may
not be reflective of overall iodine status in an individual.
A limitation of the study is that the assessment of IQ was
performed with different tools at different ages. Never-
theless, the tools measured the same construct (nonverbal
or verbal IQ), and the standardization of IQ scores in
each cohort facilitated comparison of results across
cohorts. Sensitivity analysis in older children only (e.g.,
excluding children from Generation R, thus reducing
Figure 4. Association of maternal iodine status during pregnancy with child verbal IQ score stratified by tertiles of gestational age. Continuous
association, depicted as the mean child verbal IQ (black line) with 95% CI (gray area) was restricted to (a) the first 12 weeks of gestation (lowest
tertile, median UI/Creat 116 mg/g; n 5 2209); (b) from weeks 12 to 14 of gestation (middle tertile, median UI/Creat 147 mg/g; n 5 1776); and
(c) later than week 14 of gestation (highest tertile, median UI/Creat 157 mg/g; n 5 1879). Models are adjusted for gestational age, child sex,
maternal ethnicity/country of birth, maternal education, parity, maternal age, prepregnancy body mass index, and smoking during pregnancy.
The P value was provided by an ANOVA test of the null hypothesis that mean child verbal IQ was similar across the whole range of the natural
logarithm of UI/Creat.
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the age range at which verbal IQ was assessed) con-
firmed the association between UI/Creat and verbal IQ
score. Another limitation is that UIC was measured in
different laboratories using different assays; it is known
that urinary iodine measurements vary between labo-
ratories (56). We used laboratories that were registered
with EQUIP, and the use of certified reference materials
enabled us to ensure the accuracy of the results.
In conclusion, this study confirms that iodine status in
pregnancy is associated with child IQ scores, and results
indicate that the development of verbal IQ of the fetus is
particularly vulnerable to suboptimal iodine concentra-
tion during early pregnancy up until the start of the
second trimester. As such, our results suggest that iodine
supplementation after the first 14 weeks of pregnancy
could be outside the critical period during which iodine
availability affects fetal brain development. However,
further studies should replicate these data and investigate
the effects of iodine supplementation.
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